The Delivery Materials with Chemotherapy Drugs for Treatment of the Positive Margin in Solid Tumors
- 13 May 2021
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (9-10) , 536-548
Abstract
The positive surgical margins in solid tumors has been a disturbing issue for clinicians. Chemotherapy is an important method to deal with the positive margin. However, systemic chemotherapy is required for long-term administration and has great side effects on health, which cause great pain to the patients. Local administration of slow-release materials provides an opportunity to improve the situation. In this study, we utilized electrospinning technology to create the drug sustained-release materials with nanofibrous structure, which were made from polylactic acid and a certain proportion of chemotherapy drugs (gemcitabine and cisplatin). In vitro release behavior of the drug sustained-release materials were explored by the high-performance liquid chromatography. The antitumor efficacy of the drug sustained-release materials was preliminarily verified in prostate cancer and breast cancer in vitro . Through animal models of breast cancer, the drug sustained-release materials in the treatment of the positive margin has been well documented in vivo , and we also found that the drug sustained-release materials could definitely reduce the liver damage and myelosuppression compared with systemic chemotherapy. In summary, the experimental results showed that the local administration of the drug sustained-release materials could effectively inhibit the growth of the positive incision margins and definitely reduce the partial side effects associated with systemic chemotherapy.Keywords
This publication has 29 references indexed in Scilit:
- The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2019
- Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapyBiomedicine & Pharmacotherapy, 2017
- Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder CancerOncology, 2017
- Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface EngineeringCurrent Pharmaceutical Design, 2016
- Traitements complémentaires de la chirurgie du cancer de la prostate et chirurgie de la récidiveProgrès en Urologie, 2015
- Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: In vitro and in vivo studiesColloids and Surfaces B: Biointerfaces, 2015
- Engineering Biomaterial–Drug Conjugates for Local and Sustained Chemotherapeutic DeliveryBioconjugate Chemistry, 2015
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Morphology of Elastic Poly(l-lactide-co-ε-caprolactone) Copolymers and in Vitro and in Vivo Degradation Behavior of Their ScaffoldsBiomacromolecules, 2004